Elevate Holistics Research Team
“Cannabis is our passion and our expertise. At Elevate Holistics, we’re dedicated to simplifying the complex world of medical marijuana, making it accessible and understandable for everyone.”
About
Meet the heart of Elevate Holistics – our Research Team, a dynamic group of professionals with a shared passion for all things cannabis. Our team is a melting pot of expertise, featuring doctors, pharmacists, and holistic health practitioners. Together, we blend our diverse backgrounds to offer a unique perspective on medical marijuana. We’re not just researchers; we’re educators and advocates, dedicated to demystifying the world of cannabis for our community. Our team works tirelessly to provide clear, accurate, and practical information, helping you navigate the ever-changing landscape of medical marijuana with confidence and ease.
Articles
Next Year, SXSW 2027 May Spotlight Cannabis and Psychedelics
South by Southwest just proved that cannabis at SXSW 2027 is no longer a niche conversation. Attendees can vote on seven panels that mention cannabis
Inside the Hemp Cannabinoid Ban 2026 and What It Means for HHC Consumers
Federal regulators and hemp companies are fighting over the fate of HHC, delta-8, and other synthetic cannabinoids sold nationwide. The DEA already assigned HHC its
VA Announces Psilocybin Therapy Trial for Veterans With Depression and PTSD
The Department of Veterans Affairs just opened a new clinical trial testing whether psilocybin can help veterans with treatment-resistant depression, including those who also live
Hemp THC Ban 2026: What the New Attorneys General Letter Means for You
A coalition of 35 state attorneys general just told Congress to leave the hemp THC ban 2026 alone. Their letter, published this week, urges lawmakers
Does Marijuana Legalization Increase Teen Use? Federal Studies Say No
A new federal report puts a persistent fear to rest. SAMHSA’s newly published 2025 National Survey on Drug Use and Health answers one of cannabis
Eli Lilly Just Spent $2.8 Billion on a Psychedelic Drug — Here’s Why That’s a Huge Deal
One of the largest drug companies in the world just made a $2.8 billion bet on a substance most people associate with underground rituals, not